Internal Medicine Department of University Hospital
Brest, 29200, France
NCT Number: NCT06554210
RATIONALE: HIV pathology has been associated with accelerated aging of the infected organism, with no known knowledge of virus, immunosuppression, immune response stimulation, antiretroviral toxicity, and "classic" risks. The data are in good standing from a multicenter cohort with high statistical power but very heterogeneous and not exhaustive. A complementary approach by small, comprehensive cohorts is desirable.
POPULATION CONCERNED: HIV-positive persons OBJECTIVE To describe the aging of the physiological functions of people living with HIV.
SECONDARY OBJECTIVES Assess the determinants (virus / HAART / Immunity / environment) Compare to the general population (historical comparisons) Compare to main body functions MAIN EVALUATION CRITERIA respiratory functional tests, memory test, IMTc, ECG, creatininemia, cancer, Fibroscan, bone densitometry...
SECONDARY EVALUATION CRITERIA Age, sex, phototype, CD4 lymphocytes count, viral load, nadir CD4, antiretroviral exposure, alcohol, tobacco ...
METHODOLOGY Monocentric retrospective study STATISTICS Frailty model, chi2 test, test U INCLUSION CRITERIA Seropositive for HIV, age>18 years Follow-up at least once in the Internal Medicine department between 1995 and 2018 CRITERIA OF EXCLUSION Refusal of the patient or unreachable patient NUMBER OF PATIENTS Between 200 and 300 CALENDAR Duration of inclusions: 3 months Duration of participation of the patient: 20 years (retrospectives ...) Duration of the study: 1 year
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brest, 29200, France
Rational:
HIV pathology has been associated with an accelerated aging of the infected organism, without anyone knowing how to do it:
The discordant data of the great cohorts must be supported by cohorts of smaller sizes, more exhaustive, both in item and data, more homogeneous in their social determinants.
Population and Methods:
This retrospective monocentric epidemiological study has several objectives:
Kidney: creatinine, calculated clearance of creatinine, microalbuminuria Liver: cytolysis, cholestasis, Fibroscan * pulmonary: pulmonary function tests Heart: ultrasound, ECG Brain: memory disorder screening test Psychism: depression test Musculoskeletal: Bone Densitometry, Calcium, Phosphoremia, Vitamin D Vascular: carotid intima-media thickness
Demographic: gender, age, phototype Viral: subtypes, time to infection, undetectable delay, viral load zenith Immune: lymphocyte immunophenotyping, nadir CD4 Iatrogen: antiretrovirals (year / patient exposure, compliance), other treatment Toxic: self-administered questionnaire (alcohol, tobacco and others), expired Hb CO, gammaGT, urinary toxicity test
Ethical considerations:
The data of VIHVA study, approved by the local ethics committee (CCPPRB), was collected upon obtaining the non-opposition of patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: yearly
creatinin level, creatinin clearance, microalbuminuria
Time frame: at last one
respiratory functional test
Time frame: at last one
elastometry (Fibroscan*)
Time frame: at last one
memory tests
Time frame: at last one
intima-media thickness, systolic and diastolic blood pressure
Time frame: at last one
osteodensitometry
Time frame: at last one
ECG, echography
University Hospital, Brest
Other
Acronym: VIHVA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05021913
Aging, Premature, Pathological Conditions, Signs and Symptoms
Uppsala, Sweden
View Trial DetailsNCT03487302
Aging, Premature, Cardiovascular Abnormalities
San Donato Milanese, Milano, Italy
View Trial DetailsNCT03244488
AIDS Dementia Complex, Aging, Premature
Nashville, Tennessee, United States
View Trial DetailsNCT05678660
Aging, Premature, Behavior
Mazabuka, Southern Province, Zambia
View Trial Details